SG3 Management’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Hold
0
168
2022
Q3
Hold
0
218
2022
Q2
Hold
0
385
2022
Q1
Hold
0
646
2021
Q2
Hold
0
616
2021
Q1
Hold
0
668